Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.
暂无分享,去创建一个
[1] R. Stackman,et al. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment , 2003, Experimental Neurology.
[2] M. Pericak-Vance,et al. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs , 1995, Neurobiology of Aging.
[3] Stephan Nussberger,et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.
[4] Y. L. Lin,et al. Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages. , 1999, European journal of pharmacology.
[5] B. Ahlemeyer,et al. Neuroprotective effects of Ginkgo biloba extract , 2003, Cellular and Molecular Life Sciences CMLS.
[6] R. Martins,et al. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β , 2003, Brain Research Reviews.
[7] F. V. Defeudis,et al. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.
[8] David F. Clayton,et al. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.
[9] M. Mattson,et al. Essential role for integrin linked kinase in Akt‐mediated integrin survival signaling in hippocampal neurons , 2003, Journal of neurochemistry.
[10] Subramanian Rajagopalan,et al. Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.
[11] M. Youdim,et al. Non-steroidal Anti-inflammatory Drugs Stimulate Secretion of Non-amyloidogenic Precursor Protein* , 2002, The Journal of Biological Chemistry.
[12] Jen-kun Lin,et al. Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IκB kinase activity in macrophages , 2000 .
[13] C. Rice-Evans,et al. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[14] C. Masters,et al. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.
[15] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[16] C. Lavedan. The synuclein family. , 1998, Genome research.
[17] David Blum,et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.
[18] C. Rice-Evans,et al. Dietary Flavonoids as Potential Neuroprotectants , 2002, Biological chemistry.
[19] R. Hider,et al. Metal chelation of polyphenols. , 2001, Methods in enzymology.
[20] S. Korsmeyer,et al. Bcl-2 gene family in the nervous system. , 1997, Annual review of neuroscience.
[21] S. Suh,et al. The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .
[22] W. May,et al. A Functional Role for Mitochondrial Protein Kinase Cα in Bcl2 Phosphorylation and Suppression of Apoptosis* , 1998, The Journal of Biological Chemistry.
[23] D. Tagliazucchi,et al. Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin , 2003, Brain Research Bulletin.
[24] S. Mandel,et al. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] M. Hiramatsu,et al. The efficacy of an antioxidant cocktail on lipid peroxide level and superoxide dismutase activity in aged rat brain and DNA damage in iron-induced epileptogenic foci. , 2000, Toxicology.
[26] M. Vila,et al. α‐Synuclein Up‐Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP , 2000, Journal of neurochemistry.
[27] C. Hofmann,et al. Green tea polyphenol epigallocatechin‐3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] George Adelman,et al. Encyclopedia of neuroscience , 2004 .
[29] S. Mandel,et al. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.
[30] Z. Szallasi,et al. Overexpression of Protein Kinase C Isoform but not δ in Human Interleukin-3–Dependent Cells Suppresses Apoptosis and Induces bcl-2 Expression , 1998 .
[31] M. Ebadi,et al. Ubiquinone (Coenzyme Q10) and Mitochondria in Oxidative Stress of Parkinson’s Disease , 2001, Neurosignals.
[32] J. Joseph,et al. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.
[33] Ashley I. Bush,et al. The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.
[34] Z. Y. Wang,et al. Tea and cancer. , 1993, Journal of the National Cancer Institute.
[35] S. Mandel,et al. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.
[36] M. Folstein,et al. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease , 1995, Neurology.
[37] Yona Levites,et al. Involvement of Protein Kinase C Activation and Cell Survival/ Cell Cycle Genes in Green Tea Polyphenol (−)-Epigallocatechin 3-Gallate Neuroprotective Action* , 2002, The Journal of Biological Chemistry.
[38] C. Rice-Evans,et al. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. , 2001, The Biochemical journal.
[39] S. Wessler,et al. A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation* , 2004, Journal of Biological Chemistry.
[40] Y. Lou,et al. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. , 1994, Cancer research.
[41] M. Tabata,et al. Effects of pH and Metal Ions on Antioxidative Activities of Catechins , 2001, Bioscience, biotechnology, and biochemistry.
[42] J. Greenwood,et al. Letter: Exploration of the common bileduct. , 1974, Lancet.
[43] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[44] M. Masuda,et al. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[45] S. Mandel,et al. Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs. , 2003, Trends in pharmacological sciences.
[46] D. Allsop,et al. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. , 2001, Free radical biology & medicine.
[47] S. Suh,et al. Protective effects of the green tea polyphenol (−)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils , 2000, Neuroscience Letters.
[48] Xiaofeng Meng,et al. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[49] G. Escames,et al. Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion , 2003, Neurobiology of Aging.
[50] P A Insel,et al. Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[51] E. Mandelkow,et al. Proteolysis by presenilins and the renaissance of tau. , 1999, Trends in cell biology.
[52] D. Small,et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[53] H. Mukhtar,et al. Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells , 2003, Oncogene.
[54] J. Melki,et al. Spinal muscular atrophy. , 1997, Current opinion in neurology.
[55] P. Reiner,et al. Regulation of Amyloid Precursor Protein Cleavage , 1999, Journal of neurochemistry.
[56] T. Sunderland,et al. Physiologic Levels of β‐Amyloid Activate Phosphatidylinositol 3‐Kinase with the Involvement of Tyrosine Phosphorylation , 1996, Journal of neurochemistry.
[57] R. Yu,et al. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death , 2000, Archives of pharmacal research.
[58] Tianhong Pan,et al. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury. , 2003, Life sciences.
[59] R. Motter,et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.
[60] Ji Hyun Han,et al. Dual mechanisms of green tea extract‐induced cell survival in human epidermal keratinocytes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[61] K. Senior. Dosing in phase II trial of Alzheimer's vaccine suspended , 2002, Lancet Neurology.
[62] Y. Kan,et al. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. , 1999, Bioscience, biotechnology, and biochemistry.
[63] M. Diaz-Meco,et al. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade , 1997, Molecular and cellular biology.
[64] C. Olanow,et al. Iron and neurodegeneration , 1996 .
[65] B. Frei,et al. Tea Catechins and Polyphenols: Health Effects, Metabolism, and Antioxidant Functions , 2003, Critical reviews in food science and nutrition.
[66] A. Kong,et al. Antioxidants and oxidants regulated signal transduction pathways. , 2002, Biochemical pharmacology.
[67] R. A. Oliveira,et al. Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells. , 2003, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.
[68] J. Ducobu,et al. OCULAR TOXICITY OF DESFERRIOXAMINE , 1985, The Lancet.
[69] M. Bähr,et al. Insulin-Like Growth Factor-I Protects Axotomized Rat Retinal Ganglion Cells from Secondary Death via PI3-K-Dependent Akt Phosphorylation and Inhibition of Caspase-3 In Vivo , 2000, The Journal of Neuroscience.
[70] Q. Guo,et al. Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. , 1996, Biochimica et biophysica acta.
[71] C. Heckman,et al. The sevenfold way of PKC regulation. , 1998, Cellular signalling.
[72] B. Shukitt-Hale,et al. Fruit Polyphenolics and Brain Aging , 2002 .
[73] Y. Sagara,et al. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. , 2001, Free radical biology & medicine.
[74] S. Mandel,et al. Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin , 2003, Annals of the New York Academy of Sciences.
[75] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[76] A. Takashima,et al. Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.
[77] R. Scheller,et al. The rat brain synucleins; family of proteins transiently associated with neuronal membrane. , 1991, Brain research. Molecular brain research.
[78] D. Jiang,et al. Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice , 2005, Journal of Neural Transmission.
[79] G. Johnson,et al. Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.
[80] J. Grotta,et al. Ethanol Plus Caffeine (Caffeinol) for Treatment of Ischemic Stroke: Preclinical Experience , 2003, Stroke.
[81] David R Kaplan,et al. Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.
[82] H. Hasegawa,et al. Ameliorative effects of tea catechins on active oxygen-related nerve cell injuries. , 1995, The Journal of pharmacology and experimental therapeutics.
[83] M. Kyriazis,et al. Neuroprotective, anti-apoptotic effects of apomorphine. , 2003, Journal of anti-aging medicine.
[84] K. Jellinger,et al. Neuropathological spectrum of synucleinopathies , 2003, Movement disorders : official journal of the Movement Disorder Society.
[85] D. Mochly‐Rosen,et al. Opposing roles of δ and εPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery , 2003 .
[86] M. Youdim,et al. The Future of Neuroprotection , 1999, Annals of the New York Academy of Sciences.
[87] D. Praticò,et al. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. , 2000, The American journal of medicine.
[88] K. Murai,et al. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling , 2003, Nature Neuroscience.
[89] S. Mandel,et al. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration , 2001, Journal of neurochemistry.
[90] M. Hiramatsu,et al. Effect of “βCATECHIN” on the life span of senescence accelerated mice (SAM‐P8 strain) , 1997 .
[91] L. Mucke,et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease , 1997, Brain Research Reviews.
[92] Barbara Shukitt-Hale,et al. Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.
[93] John Hardy,et al. The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity , 2000, The Journal of Neuroscience.
[94] M. Beal,et al. Bioenergetic approaches for neuroprotection in Parkinson's disease , 2003, Annals of neurology.
[95] J. Lin,et al. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. , 1999, Biochemical pharmacology.
[96] H. Xue,et al. Naturally occurring 2'-hydroxyl-substituted flavonoids as high-affinity benzodiazepine site ligands. , 2003, Biochemical pharmacology.
[97] P. Lazarovici,et al. Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections , 2002, Science.
[98] M. Youdim,et al. The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing , 2003, The FASEB Journal.
[99] C. S. Patil,et al. Protective Effect of Flavonoids against Aging- and Lipopolysaccharide-Induced Cognitive Impairment in Mice , 2003, Pharmacology.
[100] D. Ben-shachar,et al. The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons , 1991, Journal of neurochemistry.
[101] P. Riederer,et al. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.
[102] A. Mackinnon,et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.
[103] S. Mandel,et al. Neuroprotection and neurorescue against Aβ toxicity and PKC‐dependent release of non‐amyloidogenic soluble precursor protein by green tea polyphenol (‐)‐epigallocatechin‐3‐gallate , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[104] P. Bauer,et al. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra , 2003, Neuroscience Letters.
[105] R. Tyrrell,et al. Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. , 2001, The Biochemical journal.
[106] W. Kalt,et al. Feeding Rats Diets Enriched in Lowbush Blueberries for Six Weeks Decreases Ischemia-induced Brain Damage , 2002, Nutritional neuroscience.
[107] C. Rice-Evans,et al. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide , 2002, Neurobiology of Aging.
[108] J. Medina,et al. Overview—Flavonoids: A New Family of Benzodiazepine Receptor Ligands , 1997, Neurochemical Research.
[109] Y. Suh,et al. α‐Synuclein regulates neuronal survival via Bcl‐2 family expression and PI3/Akt kinase pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[110] M. Youdim,et al. Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28 , 2004, Annals of the New York Academy of Sciences.
[111] D. Deleu,et al. Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson’s Disease , 2002, Clinical pharmacokinetics.
[112] M. Chevion,et al. Protective effects of tea polyphenols against oxidative damage to red blood cells. , 1997, Biochemical pharmacology.
[113] C. Rice-Evans,et al. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. , 1995, Archives of biochemistry and biophysics.
[114] E. Masliah,et al. Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease* , 1999, The Journal of Biological Chemistry.
[115] M. Vila,et al. Neurological diseases: Targeting programmed cell death in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.
[116] D. Selkoe,et al. Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[117] F. Nanjo,et al. Scavenging effects of tea catechins and their derivatives on 1,1-diphenyl-2-picrylhydrazyl radical. , 1996, Free radical biology & medicine.
[118] K. Z. Itil,et al. A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo biloba Extract EGb 761® in Dementia , 2000, Dementia and Geriatric Cognitive Disorders.
[119] D. Dorsa,et al. The Mitogen-Activated Protein Kinase Pathway Mediates Estrogen Neuroprotection after Glutamate Toxicity in Primary Cortical Neurons , 1999, The Journal of Neuroscience.
[120] M. Youdim,et al. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats , 2004, Neuropharmacology.
[121] B. Shukitt-Hale,et al. Blueberry Supplementation Enhances Signaling and Prevents Behavioral Deficits in an Alzheimer Disease Model , 2003, Nutritional neuroscience.
[122] Harvey Checkoway,et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.
[123] J. Connor,et al. Redox-active metals in neurological disorders , 2004 .
[124] C. Rice-Evans,et al. The relative antioxidant activities of plant-derived polyphenolic flavonoids. , 1995, Free radical research.
[125] D. Selkoe,et al. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .
[126] D. Commenges,et al. Intake of flavonoids and risk of dementia , 2000, European Journal of Epidemiology.
[127] L. Mucke,et al. Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[128] S. Kohsaka,et al. Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons , 1998, Journal of neuroscience research.
[129] Y. Fujimura,et al. A receptor for green tea polyphenol EGCG , 2004, Nature Structural &Molecular Biology.
[130] C. Pike,et al. Estrogen activates protein kinase C in neurons: role in neuroprotection , 2003, Journal of neurochemistry.
[131] P. Parker,et al. Loss of protein kinase C function induces an apoptotic response , 1998, Oncogene.
[132] S. Gupta,et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[133] M. Mattson,et al. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. , 2003, Trends in molecular medicine.
[134] P. Maher. How Protein Kinase C Activation Protects Nerve Cells from Oxidative Stress-Induced Cell Death , 2001, The Journal of Neuroscience.
[135] G. Linazasoro. Neuroprotection in Parkinson’s disease: love story or mission impossible? , 2002, Expert review of neurotherapeutics.
[136] C. Olanow,et al. Neurodegeneration and Neuroprotection in Parkinson's Disease , 1996 .